Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01)

The summary for the Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01): This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health is a limited competition RFA inviting cooperative agreement (U01) applications from investigators currently participating as part of the Look AHEAD (Action for Health in Diabetes) Consortium. Look AHEAD is a clinical trial that will examine the long-term health effects of an intensive lifestyle intervention program designed to achieve and maintain weight loss in overweight and obese participants with type 2 diabetes. The purpose of this limited competition will be to allow an additional 2-year follow period of all currently enrolled participants.

Federal Grant Title:	Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-12-502
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.233
CFDA Descriptions:	National Center on Sleep Disorders Research
Current Application Deadline:	Dec 20, 2012
Original Application Deadline:	Nov 20, 2012
Posted Date:	Jun 01, 2012
Creation Date:	Sep 28, 2012
Archive Date:	Jan 21, 2013
Total Program Funding:	$23,058,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	16
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Only organizations which are currently participating in Look AHEAD are eligible to apply under this FOA.
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowe...; • NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (...; • NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (...; • Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Researc...; • Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Al...; • Ancillary Studies in Clinical Trials (R01); • Opportunity PA-08-021; • Research Demonstration and Dissemination Grants (R18)
More Grants from the National Institutes of Health: • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)